These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2311069)

  • 1. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
    Lewis WE
    Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
    Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
    Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
    Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
    Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
    Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
    Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
    Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
    Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
    Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.